Akari therapeutics plc (AKTX)
CashFlow / Quarterly
Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Cash Flows from Operating Activities:
Net loss

-6,451

-2,985

6,472

-48,752

-1,340

-1,696

-1,113

3,135

-2,229

-1,740

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

-

8

-

2

0

0

-

1

0

0

Stock-based compensation

805

816

963

76

0

0

0

-351

156

195

Changes in fair value of the liability for options and warrants

976

704

-

-

0

0

-

-

-

-

Foreign currency exchange gains

-

178

-

-

0

0

-

-

-

-

Changes in operating assets and liabilities:
Increase in assets:
Changes in values of liability related to stock options and warrants

-

-

-

-

-

-

-

-

108

151

Prepaid expenses and other current assets

328

524

562

-1,588

102

10

5

-715

559

160

(Decrease) increase in liabilities:
Accounts payable and accrued expenses

1,424

-3,876

-2,883

6,176

744

-282

-

-

-

-

Other liabilities

3

3

3

0

0

0

-

-

-

-

Total adjustments

759

-4,455

-13,242

53,243

643

-291

-

-

-

-

(Decrease) increase in trade payables

-

-

-

-

-

-

-

-

427

192

Decrease in other accounts payable

-

-

-

-

-

-

-

-

-15

-384

Increase in other long term liabilities

-

-

-

-

-

-

-

-

0

0

Net Cash Used in Operating Activities

-

-7,440

-

-

-

-1,988

-

3,567

-2,328

-2,048

Cash Flows from Investing Activities:
Purchase of property and equipment

5

42

-

-

0

0

-

-

-

-

Net Cash (Used in) Provided by Investing Activities

-

-42

-

-

-

0

-

142

-142

0

Proceeds from issuance of shares, net

-

-

-

-

-

-

-

-

-

8,219

Net Cash Provided by Financing Activities

-

-

-

-

-

-

-

-7,876

0

8,219

Effect of Exchange Rates on Cash

50

-7

-3

56

79

-10

-

-

-

-

Net Decrease in Cash

-51,767

-7,490

-9,852

78,571

-1,127

-1,998

3,274

-4,202

-2,470

6,171

Interest

-

0

-

20

0

2

-

-

-

-